| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | protein antigen binding | 1.51e-04 | 16 | 23 | 2 | GO:1990405 | |
| GeneOntologyMolecularFunction | protein binding involved in heterotypic cell-cell adhesion | 1.92e-04 | 18 | 23 | 2 | GO:0086080 | |
| GeneOntologyMolecularFunction | SH3 domain binding | 5.73e-04 | 143 | 23 | 3 | GO:0017124 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | 6.46e-04 | 149 | 23 | 3 | GO:1990782 | |
| GeneOntologyMolecularFunction | epidermal growth factor receptor binding | 1.01e-03 | 41 | 23 | 2 | GO:0005154 | |
| GeneOntologyMolecularFunction | cell-cell adhesion mediator activity | 2.23e-03 | 61 | 23 | 2 | GO:0098632 | |
| GeneOntologyMolecularFunction | protein phosphorylated amino acid binding | 2.84e-03 | 69 | 23 | 2 | GO:0045309 | |
| GeneOntologyMolecularFunction | cell adhesion mediator activity | 3.43e-03 | 76 | 23 | 2 | GO:0098631 | |
| GeneOntologyMolecularFunction | phosphoprotein binding | 7.95e-03 | 117 | 23 | 2 | GO:0051219 | |
| GeneOntologyBiologicalProcess | negative regulation of I-kappaB phosphorylation | 7.13e-06 | 4 | 23 | 2 | GO:1903720 | |
| GeneOntologyBiologicalProcess | negative regulation of chemokine production | 9.96e-06 | 38 | 23 | 3 | GO:0032682 | |
| GeneOntologyBiologicalProcess | negative regulation of macrophage inflammatory protein 1 alpha production | 1.19e-05 | 5 | 23 | 2 | GO:0071641 | |
| GeneOntologyBiologicalProcess | negative regulation of type I interferon production | 2.89e-05 | 54 | 23 | 3 | GO:0032480 | |
| GeneOntologyBiologicalProcess | regulation of macrophage inflammatory protein 1 alpha production | 3.32e-05 | 8 | 23 | 2 | GO:0071640 | |
| GeneOntologyBiologicalProcess | negative regulation of chemokine (C-C motif) ligand 5 production | 4.26e-05 | 9 | 23 | 2 | GO:0071650 | |
| GeneOntologyBiologicalProcess | macrophage inflammatory protein-1 alpha production | 4.26e-05 | 9 | 23 | 2 | GO:0071608 | |
| GeneOntologyBiologicalProcess | negative regulation of protein phosphorylation | 4.97e-05 | 375 | 23 | 5 | GO:0001933 | |
| GeneOntologyBiologicalProcess | regulation of I-kappaB phosphorylation | 5.32e-05 | 10 | 23 | 2 | GO:1903719 | |
| GeneOntologyBiologicalProcess | negative regulation of phosphorylation | 6.83e-05 | 401 | 23 | 5 | GO:0042326 | |
| GeneOntologyBiologicalProcess | cellular response to interleukin-12 | 9.21e-05 | 13 | 23 | 2 | GO:0071349 | |
| GeneOntologyBiologicalProcess | monocyte extravasation | 9.21e-05 | 13 | 23 | 2 | GO:0035696 | |
| GeneOntologyBiologicalProcess | negative regulation of interleukin-6 production | 9.41e-05 | 80 | 23 | 3 | GO:0032715 | |
| GeneOntologyBiologicalProcess | regulation of chemokine (C-C motif) ligand 5 production | 1.24e-04 | 15 | 23 | 2 | GO:0071649 | |
| GeneOntologyBiologicalProcess | negative regulation of tumor necrosis factor production | 1.38e-04 | 91 | 23 | 3 | GO:0032720 | |
| GeneOntologyBiologicalProcess | chemokine (C-C motif) ligand 5 production | 1.41e-04 | 16 | 23 | 2 | GO:0071609 | |
| GeneOntologyBiologicalProcess | response to interleukin-12 | 1.41e-04 | 16 | 23 | 2 | GO:0070671 | |
| GeneOntologyBiologicalProcess | negative regulation of tumor necrosis factor superfamily cytokine production | 1.47e-04 | 93 | 23 | 3 | GO:1903556 | |
| GeneOntologyBiologicalProcess | negative regulation of phosphate metabolic process | 1.56e-04 | 478 | 23 | 5 | GO:0045936 | |
| GeneOntologyBiologicalProcess | negative regulation of phosphorus metabolic process | 1.59e-04 | 480 | 23 | 5 | GO:0010563 | |
| GeneOntologyBiologicalProcess | negative regulation of protein modification process | 2.15e-04 | 512 | 23 | 5 | GO:0031400 | |
| GeneOntologyBiologicalProcess | negative regulation of interferon-beta production | 2.23e-04 | 20 | 23 | 2 | GO:0032688 | |
| GeneOntologyBiologicalProcess | I-kappaB phosphorylation | 2.71e-04 | 22 | 23 | 2 | GO:0007252 | |
| GeneOntologyBiologicalProcess | negative regulation of nitric oxide metabolic process | 3.51e-04 | 25 | 23 | 2 | GO:1904406 | |
| GeneOntologyBiologicalProcess | negative regulation of nitric oxide biosynthetic process | 3.51e-04 | 25 | 23 | 2 | GO:0045019 | |
| GeneOntologyBiologicalProcess | regulation of chemokine production | 3.52e-04 | 125 | 23 | 3 | GO:0032642 | |
| GeneOntologyBiologicalProcess | chemokine production | 4.41e-04 | 135 | 23 | 3 | GO:0032602 | |
| GeneOntologyBiologicalProcess | regulation of type I interferon production | 5.01e-04 | 141 | 23 | 3 | GO:0032479 | |
| GeneOntologyBiologicalProcess | type I interferon production | 5.44e-04 | 145 | 23 | 3 | GO:0032606 | |
| GeneOntologyBiologicalProcess | negative regulation of phagocytosis | 6.15e-04 | 33 | 23 | 2 | GO:0050765 | |
| GeneOntologyBiologicalProcess | regulation of type II interferon production | 6.60e-04 | 155 | 23 | 3 | GO:0032649 | |
| GeneOntologyBiologicalProcess | type II interferon production | 8.48e-04 | 169 | 23 | 3 | GO:0032609 | |
| GeneOntologyBiologicalProcess | negative regulation of multicellular organismal process | 8.79e-04 | 1488 | 23 | 7 | GO:0051241 | |
| GeneOntologyBiologicalProcess | phagocytosis, recognition | 9.97e-04 | 42 | 23 | 2 | GO:0006910 | |
| GeneOntologyBiologicalProcess | negative regulation of cytokine production involved in inflammatory response | 1.04e-03 | 43 | 23 | 2 | GO:1900016 | |
| GeneOntologyBiologicalProcess | negative regulation of JNK cascade | 1.04e-03 | 43 | 23 | 2 | GO:0046329 | |
| GeneOntologyBiologicalProcess | hematopoietic progenitor cell differentiation | 1.32e-03 | 197 | 23 | 3 | GO:0002244 | |
| GeneOntologyBiologicalProcess | negative regulation of cytokine production | 1.36e-03 | 444 | 23 | 4 | GO:0001818 | |
| GeneOntologyBiologicalProcess | regulation of T cell activation | 1.52e-03 | 458 | 23 | 4 | GO:0050863 | |
| GeneOntologyBiologicalProcess | regulation of interleukin-6 production | 1.63e-03 | 212 | 23 | 3 | GO:0032675 | |
| GeneOntologyBiologicalProcess | NADP metabolic process | 1.77e-03 | 56 | 23 | 2 | GO:0006739 | |
| GeneOntologyBiologicalProcess | interleukin-6 production | 1.83e-03 | 221 | 23 | 3 | GO:0032635 | |
| GeneOntologyBiologicalProcess | regulation of tumor necrosis factor production | 2.06e-03 | 230 | 23 | 3 | GO:0032680 | |
| GeneOntologyBiologicalProcess | regulation of tumor necrosis factor superfamily cytokine production | 2.21e-03 | 236 | 23 | 3 | GO:1903555 | |
| GeneOntologyBiologicalProcess | negative regulation of response to external stimulus | 2.24e-03 | 509 | 23 | 4 | GO:0032102 | |
| GeneOntologyBiologicalProcess | tumor necrosis factor production | 2.24e-03 | 237 | 23 | 3 | GO:0032640 | |
| GeneOntologyBiologicalProcess | negative regulation of inflammatory response | 2.29e-03 | 239 | 23 | 3 | GO:0050728 | |
| GeneOntologyBiologicalProcess | tumor necrosis factor superfamily cytokine production | 2.40e-03 | 243 | 23 | 3 | GO:0071706 | |
| GeneOntologyBiologicalProcess | response to reactive oxygen species | 2.49e-03 | 246 | 23 | 3 | GO:0000302 | |
| GeneOntologyBiologicalProcess | phagocytosis, engulfment | 2.67e-03 | 69 | 23 | 2 | GO:0006911 | |
| GeneOntologyBiologicalProcess | interferon-beta production | 2.98e-03 | 73 | 23 | 2 | GO:0032608 | |
| GeneOntologyBiologicalProcess | regulation of interferon-beta production | 2.98e-03 | 73 | 23 | 2 | GO:0032648 | |
| GeneOntologyBiologicalProcess | cellular response to insulin stimulus | 3.27e-03 | 271 | 23 | 3 | GO:0032869 | |
| GeneOntologyBiologicalProcess | plasma membrane invagination | 3.39e-03 | 78 | 23 | 2 | GO:0099024 | |
| GeneOntologyBiologicalProcess | cellular response to cytokine stimulus | 3.72e-03 | 967 | 23 | 5 | GO:0071345 | |
| GeneOntologyBiologicalProcess | cellular response to hydrogen peroxide | 3.74e-03 | 82 | 23 | 2 | GO:0070301 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell activation | 3.96e-03 | 290 | 23 | 3 | GO:0050870 | |
| GeneOntologyBiologicalProcess | cellular extravasation | 4.01e-03 | 85 | 23 | 2 | GO:0045123 | |
| GeneOntologyBiologicalProcess | regulation of cytokine production involved in inflammatory response | 4.01e-03 | 85 | 23 | 2 | GO:1900015 | |
| GeneOntologyBiologicalProcess | cellular response to interleukin-1 | 4.01e-03 | 85 | 23 | 2 | GO:0071347 | |
| GeneOntologyBiologicalProcess | regulation of epidermal growth factor receptor signaling pathway | 4.11e-03 | 86 | 23 | 2 | GO:0042058 | |
| GeneOntologyBiologicalProcess | membrane invagination | 4.20e-03 | 87 | 23 | 2 | GO:0010324 | |
| GeneOntologyCellularComponent | mitochondrial outer membrane | 2.26e-03 | 241 | 23 | 3 | GO:0005741 | |
| GeneOntologyCellularComponent | organelle outer membrane | 3.42e-03 | 279 | 23 | 3 | GO:0031968 | |
| GeneOntologyCellularComponent | outer membrane | 3.49e-03 | 281 | 23 | 3 | GO:0019867 | |
| MousePheno | increased megakaryocyte cell number | 3.42e-05 | 45 | 20 | 3 | MP:0008254 | |
| Domain | C1-set | 2.00e-03 | 54 | 23 | 2 | PF07654 | |
| Domain | IGc1 | 2.15e-03 | 56 | 23 | 2 | SM00407 | |
| Domain | Ig_C1-set | 2.30e-03 | 58 | 23 | 2 | IPR003597 | |
| Domain | IGv | 3.81e-03 | 75 | 23 | 2 | SM00406 | |
| Pathway | REACTOME_SIGNAL_REGULATORY_PROTEIN_FAMILY_INTERACTIONS | 9.55e-05 | 14 | 15 | 2 | MM15011 | |
| Pathway | REACTOME_SIGNAL_REGULATORY_PROTEIN_FAMILY_INTERACTIONS | 1.26e-04 | 16 | 15 | 2 | M925 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 36202053 | ||
| Pubmed | Requirement of SIRPα for protective immunity against Leishmania major. | 1.37e-06 | 3 | 24 | 2 | 20854790 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 33074246 | ||
| Pubmed | Central nervous system antigen P84 can serve as a substrate for neurite outgrowth. | 1.37e-06 | 3 | 24 | 2 | 2303162 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 16141346 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 15034021 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 31883525 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 23504854 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 17617577 | ||
| Pubmed | Resistance to collagen-induced arthritis in SHPS-1 mutant mice. | 1.37e-06 | 3 | 24 | 2 | 18455510 | |
| Pubmed | Regulation of Phagocyte Migration by Signal Regulatory Protein-Alpha Signaling. | 1.37e-06 | 3 | 24 | 2 | 26057870 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 26222253 | ||
| Pubmed | Essential roles of SHPS-1 in induction of contact hypersensitivity of skin. | 1.37e-06 | 3 | 24 | 2 | 18809435 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 23842779 | ||
| Pubmed | Essential roles of SIRPα in homeostatic regulation of skin dendritic cells. | 1.37e-06 | 3 | 24 | 2 | 20955735 | |
| Pubmed | A role for SHPS-1/SIRPalpha in Concanavalin A-dependent production of MMP-9. | 1.37e-06 | 3 | 24 | 2 | 17825046 | |
| Pubmed | Signal regulatory protein alpha (SIRPalpha)/CD47 interaction and function. | 1.37e-06 | 3 | 24 | 2 | 19223164 | |
| Pubmed | SIRPα deficiency accelerates the pathologic process in models of Parkinson disease. | 1.37e-06 | 3 | 24 | 2 | 31322787 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 18233962 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 9271230 | ||
| Pubmed | Soluble SIRP-Alpha Promotes Murine Acute Lung Injury Through Suppressing Macrophage Phagocytosis. | 1.37e-06 | 3 | 24 | 2 | 35634325 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 10585853 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 23559001 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 12167615 | ||
| Pubmed | Signal regulatory protein alpha initiates cachexia through muscle to adipose tissue crosstalk. | 1.37e-06 | 3 | 24 | 2 | 31507080 | |
| Pubmed | The Rho kinase pathway regulates the migration of dendritic cells through SIRP-α. | 1.37e-06 | 3 | 24 | 2 | 22391241 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 9348339 | ||
| Pubmed | Targeting SIRP-α protects from type 2-driven allergic airway inflammation. | 1.37e-06 | 3 | 24 | 2 | 21108471 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 16920950 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 17109464 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 22671569 | ||
| Pubmed | Signal regulatory protein α negatively regulates mast-cell activation following FcεRI aggregation. | 1.37e-06 | 3 | 24 | 2 | 23504624 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 23472187 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 22988019 | ||
| Pubmed | Hypothermia-induced tyrosine phosphorylation of SIRPα in the brain. | 1.37e-06 | 3 | 24 | 2 | 22468987 | |
| Pubmed | Endothelial SIRPα signaling controls VE-cadherin endocytosis for thymic homing of progenitor cells. | 1.37e-06 | 3 | 24 | 2 | 35511221 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 34917090 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 30894504 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 17475843 | ||
| Pubmed | Inhibitory regulation of osteoclast bone resorption by signal regulatory protein alpha. | 1.37e-06 | 3 | 24 | 2 | 19667119 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 18635660 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 28669759 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 29914984 | ||
| Pubmed | Focal cerebral ischemia upregulates SHP-1 in reactive astrocytes in juvenile mice. | 1.37e-06 | 3 | 24 | 2 | 12742627 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 25236797 | ||
| Pubmed | SHPS-1 regulates integrin-mediated cytoskeletal reorganization and cell motility. | 1.37e-06 | 3 | 24 | 2 | 11118207 | |
| Pubmed | Dendritic cell SIRPα regulates homeostasis of dendritic cells in lymphoid organs. | 1.37e-06 | 3 | 24 | 2 | 25818708 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 23022485 | ||
| Pubmed | Anti-SIRPα antibody immunotherapy enhances neutrophil and macrophage antitumor activity. | 1.37e-06 | 3 | 24 | 2 | 29158380 | |
| Pubmed | Deficiency in SIRP-α cytoplasmic recruitment confers protection from acute kidney injury. | 1.37e-06 | 3 | 24 | 2 | 31370677 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 34050181 | ||
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 25817792 | ||
| Pubmed | Ectodomain shedding of SHPS-1 and its role in regulation of cell migration. | 1.37e-06 | 3 | 24 | 2 | 15123722 | |
| Pubmed | A functional subset of CD8+ T cells during chronic exhaustion is defined by SIRPα expression. | 1.37e-06 | 3 | 24 | 2 | 30770827 | |
| Pubmed | Signal regulatory protein α protects podocytes through promoting autophagic activity. | 1.37e-06 | 3 | 24 | 2 | 30888336 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 12134038 | ||
| Pubmed | Podocyte SIRPα reduction aggravates lupus nephritis via promoting T cell inflammatory responses. | 1.37e-06 | 3 | 24 | 2 | 38758648 | |
| Pubmed | 1.37e-06 | 3 | 24 | 2 | 31099900 | ||
| Pubmed | Loss of microglial SIRPα promotes synaptic pruning in preclinical models of neurodegeneration. | 1.37e-06 | 3 | 24 | 2 | 33795678 | |
| Pubmed | HSF1 promotes the viability of islet β-cells via upregulating SIRPα expression. | 2.74e-06 | 4 | 24 | 2 | 32141563 | |
| Pubmed | CD47 restricts antiviral function of alveolar macrophages during influenza virus infection. | 2.74e-06 | 4 | 24 | 2 | 36437873 | |
| Pubmed | Enhanced phagocytosis of CD47-deficient red blood cells by splenic macrophages requires SHPS-1. | 2.74e-06 | 4 | 24 | 2 | 16580635 | |
| Pubmed | 2.74e-06 | 4 | 24 | 2 | 22042861 | ||
| Pubmed | SIRPα Mediates IGF1 Receptor in Cardiomyopathy Induced by Chronic Kidney Disease. | 2.74e-06 | 4 | 24 | 2 | 35722884 | |
| Pubmed | 2.74e-06 | 4 | 24 | 2 | 16697668 | ||
| Pubmed | 2.74e-06 | 4 | 24 | 2 | 35413056 | ||
| Pubmed | 2.74e-06 | 4 | 24 | 2 | 12446684 | ||
| Pubmed | Synapse maturation by activity-dependent ectodomain shedding of SIRPα. | 2.74e-06 | 4 | 24 | 2 | 24036914 | |
| Pubmed | An essential role for the association of CD47 to SHPS-1 in skeletal remodeling. | 2.74e-06 | 4 | 24 | 2 | 21638321 | |
| Pubmed | 2.74e-06 | 4 | 24 | 2 | 23049778 | ||
| Pubmed | Macrophages require Skap2 and Sirpα for integrin-stimulated cytoskeletal rearrangement. | 2.74e-06 | 4 | 24 | 2 | 22976304 | |
| Pubmed | Regulation by SIRPα of dendritic cell homeostasis in lymphoid tissues. | 2.74e-06 | 4 | 24 | 2 | 20682853 | |
| Pubmed | 2.74e-06 | 4 | 24 | 2 | 23990469 | ||
| Pubmed | 2.74e-06 | 4 | 24 | 2 | 24101669 | ||
| Pubmed | 2.74e-06 | 4 | 24 | 2 | 34097709 | ||
| Pubmed | 2.74e-06 | 4 | 24 | 2 | 23515050 | ||
| Pubmed | TLR5 mediates CD172α(+) intestinal lamina propria dendritic cell induction of Th17 cells. | 2.74e-06 | 4 | 24 | 2 | 26907705 | |
| Pubmed | Surfactant protein D prevents mucin overproduction in airway goblet cells via SIRPα. | 2.74e-06 | 4 | 24 | 2 | 38245585 | |
| Pubmed | 2.74e-06 | 4 | 24 | 2 | 32768386 | ||
| Pubmed | Dual regulation of SIRPalpha phosphorylation by integrins and CD47. | 2.74e-06 | 4 | 24 | 2 | 17584740 | |
| Pubmed | 2.74e-06 | 4 | 24 | 2 | 37095207 | ||
| Pubmed | 2.74e-06 | 4 | 24 | 2 | 20299253 | ||
| Pubmed | 2.74e-06 | 4 | 24 | 2 | 34237430 | ||
| Pubmed | 2.74e-06 | 4 | 24 | 2 | 19771158 | ||
| Pubmed | 2.74e-06 | 4 | 24 | 2 | 33028619 | ||
| Pubmed | CD47 Protects Synapses from Excess Microglia-Mediated Pruning during Development. | 2.74e-06 | 4 | 24 | 2 | 30308165 | |
| Pubmed | 2.74e-06 | 4 | 24 | 2 | 26085683 | ||
| Pubmed | 2.74e-06 | 4 | 24 | 2 | 9712903 | ||
| Pubmed | 2.74e-06 | 4 | 24 | 2 | 24269920 | ||
| Pubmed | Prion pathogenesis is unaltered in the absence of SIRPα-mediated "don't-eat-me" signaling. | 2.74e-06 | 4 | 24 | 2 | 28545141 | |
| Pubmed | 2.74e-06 | 4 | 24 | 2 | 8810330 | ||
| Pubmed | 2.74e-06 | 4 | 24 | 2 | 10477552 | ||
| Pubmed | Target cell CD47 regulates macrophage activation and erythrophagocytosis. | 2.74e-06 | 4 | 24 | 2 | 16564725 | |
| Pubmed | 2.74e-06 | 4 | 24 | 2 | 9073522 | ||
| Pubmed | 2.74e-06 | 4 | 24 | 2 | 18728125 | ||
| Pubmed | 2.74e-06 | 4 | 24 | 2 | 24143245 | ||
| Pubmed | 2.74e-06 | 4 | 24 | 2 | 33416832 | ||
| Pubmed | Negative regulation of phagocytosis in murine macrophages by the Src kinase family member, Fgr. | 2.74e-06 | 4 | 24 | 2 | 10662797 | |
| Pubmed | 2.74e-06 | 4 | 24 | 2 | 32294445 | ||
| Pubmed | Augmentation of CD47/SIRPα signaling protects cones in genetic models of retinal degeneration. | 2.74e-06 | 4 | 24 | 2 | 34197341 | |
| Interaction | SIRPA interactions | 5.62e-06 | 100 | 24 | 4 | int:SIRPA | |
| Interaction | PLEKHN1 interactions | 3.74e-05 | 55 | 24 | 3 | int:PLEKHN1 | |
| Cytoband | 2p21 | 4.70e-04 | 61 | 24 | 2 | 2p21 | |
| Cytoband | 20p13 | 1.31e-03 | 102 | 24 | 2 | 20p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr20p13 | 1.89e-03 | 123 | 24 | 2 | chr20p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3q13 | 5.94e-03 | 221 | 24 | 2 | chr3q13 | |
| GeneFamily | CD molecules|V-set domain containing|C1-set domain containing|Signal regulatory proteins | 8.31e-06 | 5 | 17 | 2 | 747 | |
| GeneFamily | C1-set domain containing | 7.01e-04 | 42 | 17 | 2 | 591 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 1.01e-02 | 163 | 17 | 2 | 590 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.36e-08 | 146 | 24 | 5 | cffa91d76606f74553d81150adbb23b003746316 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.72e-08 | 153 | 24 | 5 | e7d20c88466ff81db613869cf7a6a4bb95fd6c2f | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-CD4+_Th|normal_Pleural_Fluid / Location, Cell class and cell subclass | 8.30e-05 | 159 | 24 | 3 | ebd840ac2b07e62086ee7b5bb01c21804a0fdc7b | |
| ToppCell | TCGA-Lung-Solid_Tissue_Normal|TCGA-Lung / Sample_Type by Project: Shred V9 | 9.43e-05 | 166 | 24 | 3 | a8ebdd3cb7f59b3feeaacda45ce6d40d10db556f | |
| ToppCell | TCGA-Lung-Solid_Tissue_Normal-Lung|TCGA-Lung / Sample_Type by Project: Shred V9 | 9.43e-05 | 166 | 24 | 3 | c64971c27cb445dffc5a636d4b6a60261b93a2db | |
| ToppCell | TCGA-Lung-Solid_Tissue_Normal-Lung-Lung_normal_tissue-6|TCGA-Lung / Sample_Type by Project: Shred V9 | 9.43e-05 | 166 | 24 | 3 | 188f2575511f418216874aed9118aa6f165252cb | |
| ToppCell | TCGA-Lung-Solid_Tissue_Normal-Lung-Lung_normal_tissue|TCGA-Lung / Sample_Type by Project: Shred V9 | 9.43e-05 | 166 | 24 | 3 | 2f3072a7af048f184d33065fdd36153fd563155a | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-CD8+/CD4+_Mixed_Th|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 9.60e-05 | 167 | 24 | 3 | c0c944eae0514dc8e00d0c2892a0792e157695ec | |
| ToppCell | T_cells-TFH-like_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.16e-04 | 178 | 24 | 3 | e2ae43e5ec31de6197f2cbd6089f944adbf0a163 | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 1.18e-04 | 179 | 24 | 3 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | AT1_cells-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 1.20e-04 | 180 | 24 | 3 | 2d52cb5f77dde0e3dccac1333d4ec67ec680fcb2 | |
| ToppCell | AT1-AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.26e-04 | 183 | 24 | 3 | 6821dca076318115d360ff426eb1218cfe104063 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.32e-04 | 186 | 24 | 3 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 1.34e-04 | 187 | 24 | 3 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.38e-04 | 189 | 24 | 3 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | droplet-Trachea-nan-3m-Epithelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 190 | 24 | 3 | 434de72dde09644efbddcaa643a4a3eaf5f643bf | |
| ToppCell | droplet-Trachea-3m-Epithelial-airway_epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.41e-04 | 190 | 24 | 3 | 01e7747547ea1f3049a11a1717565ba71dd52bdc | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 190 | 24 | 3 | 5cea8298c8336c136ba009630c9e48d4bc832cb2 | |
| ToppCell | droplet-Trachea-nan-3m-Epithelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 190 | 24 | 3 | e647f9a2dcf7f2dffef53c45bbe171416518fd59 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 1.41e-04 | 190 | 24 | 3 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | droplet-Trachea-3m-Epithelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.41e-04 | 190 | 24 | 3 | 0114cf48612d78c3ada4d8a05850501fef6892c5 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 190 | 24 | 3 | c247562df3e1aa3173c9f01a74d5831f0764a1b2 | |
| ToppCell | (09)_Interm._secr.>cil.-(0)_Reference|(09)_Interm._secr.>cil. / shred by cell type by condition | 1.43e-04 | 191 | 24 | 3 | e63432718d62d39165ba8a66e14bb38c93907ffe | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-04 | 191 | 24 | 3 | 963f4f2e852bbb4faf070aafb0d368297abacd3b | |
| ToppCell | E15.5-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.43e-04 | 191 | 24 | 3 | 402c341b00f98e8215458766b3c219fff8dcb447 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 191 | 24 | 3 | e1ec165ba6578cefd88895e7e183190e79f733a4 | |
| ToppCell | 15-Airway-Epithelial-Secretory_progenitor|Airway / Age, Tissue, Lineage and Cell class | 1.43e-04 | 191 | 24 | 3 | 9359d8c6b00f8977848986baf3c950157adf4c9a | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 191 | 24 | 3 | 297bc79adc5fef211497819b4861b52cd26ac754 | |
| ToppCell | E15.5-Epithelial-alveolar_epithelial_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.45e-04 | 192 | 24 | 3 | 567f4355a01aae1f2eafc16fe86d1538a62030ab | |
| ToppCell | (10)_Ciliated-(0)_Reference|(10)_Ciliated / shred by cell type by condition | 1.49e-04 | 194 | 24 | 3 | f9d5bf6baddbd88947e6a740805962109649ed3b | |
| ToppCell | (7)_Epithelial-I_(AT1)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.54e-04 | 196 | 24 | 3 | 150554fa06868d29b0608189862eef6505ba757f | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-AT1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.54e-04 | 196 | 24 | 3 | 6856317cd0cdcb88fe54b4ae905d91e13495b1c4 | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-AT1-AT1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.54e-04 | 196 | 24 | 3 | 6731fef8c148b6681d6ed38afdf23c8213e0bbbe | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.56e-04 | 197 | 24 | 3 | e344455e62b3fe94bb242dc0db58d19a1d3878c7 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.56e-04 | 197 | 24 | 3 | c9c968e223e7814cd8d22975d849a31b7e0af7aa | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 1.56e-04 | 197 | 24 | 3 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.56e-04 | 197 | 24 | 3 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.56e-04 | 197 | 24 | 3 | 734b8db5bb4917c9ce92ed342fe6c22b64b0d3c5 | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-stalk_late|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.59e-04 | 198 | 24 | 3 | 1851b7f4198b42c21c934e2fbda39dbd65e2625c | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-2_Progenitor-AT2_Progenitor|Control_saline / Treatment groups by lineage, cell group, cell type | 1.59e-04 | 198 | 24 | 3 | 030ef63e2fc5b3d601c1a48462d797aa19ee7ff5 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.61e-04 | 199 | 24 | 3 | 1c70e7d6bd25980e1b92aa1cac3f3c95d9651b4b | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_alveolar-AT1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.61e-04 | 199 | 24 | 3 | aca81a879ef9c196bd1885eff4c63ffe6c9682b7 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.63e-04 | 200 | 24 | 3 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | proximal-Epithelial-Alveolar_Epithelial_Type_1|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.63e-04 | 200 | 24 | 3 | c1345893e6947ccf9b41282d0e4428dbfb8bcc27 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-OPC_related|10w / Sample Type, Dataset, Time_group, and Cell type. | 1.63e-04 | 200 | 24 | 3 | 8f5d98f962ddd8c4658c89ff8a2894de1228562a | |
| ToppCell | Parenchymal-10x3prime_v2-Epithelial-Epi_alveolar-AT1|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.63e-04 | 200 | 24 | 3 | 3d51aebf626dd4656ab4aac8a20d761b8062c42d | |
| ToppCell | proximal-Epithelial-Alveolar_Epithelial_Type_1-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.63e-04 | 200 | 24 | 3 | b652bc73adfdeccbdcd74497ab6e2085e5c95e88 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-AT1|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.63e-04 | 200 | 24 | 3 | 3a9633f5913f12b6865fc777c84f3f3ba795a78d | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 1.63e-04 | 200 | 24 | 3 | eac33be484dc443794e66e473f03e98406c2983e | |
| ToppCell | proximal-3-Epithelial-Alveolar_Epithelial_Type_1|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.63e-04 | 200 | 24 | 3 | 51f8fc43c069f2c4e75588d28ae6deb5d7ed2c86 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-OPC_related-Oligodendrocyte/OPC|10w / Sample Type, Dataset, Time_group, and Cell type. | 1.63e-04 | 200 | 24 | 3 | 345f1eac498cc87fd7bf08e7312608b2d6fe1dd7 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 1.63e-04 | 200 | 24 | 3 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-1|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.64e-03 | 112 | 24 | 2 | 518b7ab98b988b23f3d0f0e1f4fe90a7068f9d87 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-dn_T-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.06e-03 | 126 | 24 | 2 | 13333101d52300fc45fb9f7ca05cace502c72186 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-dn_T|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.06e-03 | 126 | 24 | 2 | 5d13a2a37efd2645d2859f02e5abb36864896bbe | |
| ToppCell | Control-Lymphoid_T/NK-dn_T|Control / Disease group, lineage and cell class | 2.09e-03 | 127 | 24 | 2 | 58f47cb079c596a9119d8bf158c1681b28360ac3 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-dn_T-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.09e-03 | 127 | 24 | 2 | d4c6e65a4e4c2c9422bea11b9f78e4beabf04961 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-dn_T|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.09e-03 | 127 | 24 | 2 | 4ccda89414f18313269be2f5a1542314b1b10572 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.19e-03 | 130 | 24 | 2 | 6434d9106ccb38786dad36fab80163dfc07b6eb7 | |
| ToppCell | TCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Spindle_Cell-2|TCGA-Uvea / Sample_Type by Project: Shred V9 | 2.40e-03 | 136 | 24 | 2 | b460669c13ed43ff3885acd38ce18f75d693738d | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-03 | 137 | 24 | 2 | e9b88ad86b75454a8292a94879c5b665adc42744 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.47e-03 | 138 | 24 | 2 | 2e46d546ad962aa0fde5b1c18c2a5370a4424e9f | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-03 | 141 | 24 | 2 | 4aa4b3476dc5abefbd348353cfe711cd5fe3d52f | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-03 | 141 | 24 | 2 | e40c6f1b7fbaa46b3eaa55f1b37ef360b04370a8 | |
| ToppCell | PBMC-Mild-cDC_7|Mild / Compartment, Disease Groups and Clusters | 2.61e-03 | 142 | 24 | 2 | 58f66f35646f281e64d634e6c26adbd1d4e6c830 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-AT2_Progenitor|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.61e-03 | 142 | 24 | 2 | 94e277f038f4006d99ff50222b0f5cf89bc3d46d | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-03 | 142 | 24 | 2 | 759fbbd15b4fb313bd6269b7f087edafebd530ef | |
| ToppCell | PND01-03-samps-Mesenchymal-Myofibroblast-myofibroblast_-_immature_2|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.64e-03 | 143 | 24 | 2 | abe6ec0f6956b87f394d537926eb2427fcfad93f | |
| ToppCell | IIH-CD8-proli_CD4|IIH / Condition, Cell_class and T cell subcluster | 2.75e-03 | 146 | 24 | 2 | 7fa6e35def3f7cffbee1e1c2f10b523bab678e14 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.79e-03 | 147 | 24 | 2 | e99197e3c2e9d63153cc55ae62b30b8363c2267e | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.90e-03 | 150 | 24 | 2 | 744050a1b665c6989f37141348af3df7579a73c9 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-03 | 150 | 24 | 2 | a3a4710820a244116a26204f40e7113a1e7236c5 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-03 | 150 | 24 | 2 | 13dcd519dacf08d5852aa3e029e0a3308de07321 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_4|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.98e-03 | 152 | 24 | 2 | eb7ff36792c3c54ac88cfe976f84016b70b1a1d7 | |
| ToppCell | Basal_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.98e-03 | 152 | 24 | 2 | 72499e4d2b374ef5f1621c89d94727ecf4bd4d5d | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.98e-03 | 152 | 24 | 2 | 6d02b50e9e9ecf820f84a79e46d153a4840a1cfe | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.02e-03 | 153 | 24 | 2 | e7a074ea8232bacf924be78a244a8507c7e1ebc8 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.02e-03 | 153 | 24 | 2 | 7518187a5fbf6c0881182dc79bd37c2d49f92b2e | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.02e-03 | 153 | 24 | 2 | 93d36723f01c2df39feebf20f3eba5b4fb4cdf59 | |
| ToppCell | Control-PLT_4|World / Disease Group and Platelet Clusters | 3.06e-03 | 154 | 24 | 2 | a2a03c5e6759c45aeeedf1e68ecb5a0112ef9a20 | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 3.10e-03 | 155 | 24 | 2 | 335cd798afbaa0a3a3e1dc558a81cfa32da48983 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-Tregs|GI_small-bowel / Manually curated celltypes from each tissue | 3.10e-03 | 155 | 24 | 2 | d4ef25965a15eab7679478b9b661e1b4a92f1c59 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Papillary_Adenocarcinoma|TCGA-Lung / Sample_Type by Project: Shred V9 | 3.10e-03 | 155 | 24 | 2 | 57259549d7ad97d9f628b821417be5ddac7dbff7 | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.14e-03 | 156 | 24 | 2 | fc8b8aef29d6d1c0f0c1d08280d8aaff8d30535e | |
| ToppCell | TCGA-Testes-Primary_Tumor-Testicular_Germ_Cell_Tumor-Testicular_Germ_Cell_Tumor|TCGA-Testes / Sample_Type by Project: Shred V9 | 3.14e-03 | 156 | 24 | 2 | f9eb18a0f00de211fab36d7d88fcf08276d53dcc | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.21e-03 | 158 | 24 | 2 | 1cefb82b9bf79c687a119be568cfc15b14c6e040 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-Tregs|Lung / Manually curated celltypes from each tissue | 3.21e-03 | 158 | 24 | 2 | f433bc189f000efa34e8e09ab32b3fa22bcf64c4 | |
| ToppCell | COVID-19_Moderate-MAIT|COVID-19_Moderate / disease group, cell group and cell class | 3.25e-03 | 159 | 24 | 2 | 6d08d670c34eb6bb8ad5dad3293b3107c006236d | |
| ToppCell | ICU-NoSEP-Lymphocyte-T_NK-CD8_TCM|ICU-NoSEP / Disease, Lineage and Cell Type | 3.29e-03 | 160 | 24 | 2 | a1bf6ed365cbc1ddb57c132a42dbe6485d45f544 | |
| ToppCell | COVID-19_Moderate-MAIT|World / disease group, cell group and cell class | 3.29e-03 | 160 | 24 | 2 | bf73c5fe87c1f243edec17d7a2c30fae5e2cfd6b | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.29e-03 | 160 | 24 | 2 | c2b5fadb4bac17fafc08831f6d3f4ff96ada7e70 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-03 | 161 | 24 | 2 | 249c2b97cc25de5053f5048ee354615df49b2081 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.38e-03 | 162 | 24 | 2 | fbb0cc2b1434a340dc35058b77c73ea61004c252 | |
| ToppCell | facs-Lung-Endomucin-24m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-03 | 162 | 24 | 2 | 497ae9f86a5e7946d0fde932b35719a382a6b691 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.38e-03 | 162 | 24 | 2 | 45be019b50e3727fc9d3fad2ff78e74e4f2d746b | |
| ToppCell | facs-Lung-Endomucin-24m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-03 | 162 | 24 | 2 | 7b2949eba2b4aea239d96ed82aafab13b07624eb | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.42e-03 | 163 | 24 | 2 | 4af92b211d12c5b88b65bb746242cd702b545bd0 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.42e-03 | 163 | 24 | 2 | cab65dabeea58141c649e4fec5e0123beb3de1b3 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Adult / Lineage, Cell type, age group and donor | 3.42e-03 | 163 | 24 | 2 | e819a1d6d28290854aa0672b3a18fa9e293d8f23 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Lymphocytic-CD4+_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.42e-03 | 163 | 24 | 2 | d24774e0aa612322c22fdb3b314aef275fa01d68 | |
| Disease | signal-regulatory protein beta-1 measurement | 1.90e-05 | 9 | 22 | 2 | EFO_0802069 | |
| Disease | narcolepsy-cataplexy syndrome | 8.85e-04 | 59 | 22 | 2 | MONDO_0016158 | |
| Disease | immature platelet count | 2.82e-03 | 106 | 22 | 2 | EFO_0803544 | |
| Disease | white matter microstructure measurement | 2.93e-03 | 390 | 22 | 3 | EFO_0005674 | |
| Disease | immature platelet fraction | 3.25e-03 | 114 | 22 | 2 | EFO_0009187 | |
| Disease | immature platelet measurement | 3.53e-03 | 119 | 22 | 2 | EFO_0803541 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HKCSHFPDFSYSASS | 401 | Q8WY36 | |
| CHFADCPFSGTSTHF | 1501 | Q86V15 | |
| PAGSTPSFCHHFSTQ | 21 | P22570 | |
| FSPDGNHFACTDSHG | 521 | Q6RI45 | |
| GLHEFADSQFGHCFS | 691 | O00763 | |
| FKFSFGNSSHVECPH | 341 | Q8NFR9 | |
| AFFSFFTHCFGHDIP | 256 | Q96RD3 | |
| APAASLGFCFHHAES | 106 | P53370 | |
| SHSSDFPCSDTFSNF | 856 | Q14693 | |
| CRTSPHSFAFYSDDH | 191 | Q8WWR8 | |
| AAAHCPFSLSYSFHS | 506 | Q16825 | |
| GHEFFDFSSGSSHAE | 36 | Q6TFL4 | |
| THHPGCLFFTFFSQE | 231 | P03951 | |
| HSETCHFDPAVFAAS | 321 | Q13751 | |
| HRTFSHFSCGSQPAA | 26 | P0C5K7 | |
| CHTFTFSHATFCGPV | 456 | P14373 | |
| NFSFDAHDPCVFHSS | 436 | O75159 | |
| VCSVFDSDHSSPFHS | 1101 | Q07889 | |
| EHTVSFTCESHGFSP | 161 | Q9P1W8 | |
| PEHTVSFTCESHGFS | 161 | O00241 | |
| NHFSPCHFLASTDDG | 351 | Q13610 | |
| HHDAFFSPSNSCLLF | 181 | Q9BS91 | |
| VSGDTFHSFPHSDFE | 301 | P58005 | |
| EFGASSFFHSPASCH | 916 | Q70EL1 | |
| SFFHSPASCHESHSS | 921 | Q70EL1 |